F-group (family)
2002.1.1.23 IMPDH
Ligands and drugs
1,033
Member domains
625
with ligand contacts (≤ 4 Å)
60.5% of members
408
with DrugDomain annotations
39.5% of members
403
with a DrugBank compound
39.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.1.1.23 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04566 | IMP | Inosinic Acid | 300 |
| DB14128 | NAD | Nadide | 140 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 76 |
| DB00171 | ATP | ATP | 68 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 32 |
| DB04022 | G4P | Guanosine tetraphosphate | 16 |
| DB01024 | MOA | Mycophenolic acid | 9 |
| DB02309 | XMP | 5-monophosphate-9-beta-D-ribofuranosyl xanthine | 8 |
| DB02338 | NDP | NADPH | 8 |
| DB03948 | CPR | 6-Chloropurine Riboside, 5'-Monophosphate | 7 |
| DB04349 | PGO | (S)-propane-1,2-diol | 6 |
| DB01945 | MZP | 4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate | 4 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 4 |
| DB14663 | RVP | Ribavirin monophosphate | 4 |
| DB00157 | — | NADH | 2 |
| DB00688 | — | — | 2 |
| DB00811 | — | Ribavirin | 2 |
| DB03070 | SAE | Selenazole-4-carboxyamide-adenine dinucleotide | 2 |
| DB06408 | — | Taribavirin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| IMP | INOSINIC ACID | 433 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 217 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 140 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 123 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 103 |
| Kmetal | POTASSIUM ION | 76 |
| XMP | XANTHOSINE-5'-MONOPHOSPHATE | 17 |
| G4P | GUANOSINE-5',3'-TETRAPHOSPHATE | 16 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 10 |
| 2F0 | 2-chloro-5-{[(2-{3-[(1E)-N-hydroxyethanimidoyl]phenyl}propan-2-yl)carbamoyl]amino}benzamide | 8 |
| 39H | 2-(3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)-N-(6,7,8,9-tetrahydrodibenzo[b,d]furan-2-yl)acetamide | 8 |
| 8L4 | 3-(2-{[(4-chlorophenyl)carbamoyl]amino}propan-2-yl)-N-hydroxybenzene-1-carboximidamide | 8 |
| 8LA | N-[4-chloro-3-(alpha-D-ribofuranosyloxy)phenyl]-N'-{2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}urea | 8 |
| A1A7T | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-[3-(thiophen-2-ylcarbonylamino)pyridin-1-yl]oxolan-2-yl]methyl hydrogen phosphate | 8 |
| C91 | N-(naphthalen-2-yl)-2-[2-(pyridin-2-yl)-1H-benzimidazol-1-yl]acetamide | 8 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 8 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 8 |
| P68 | 1-(4-bromophenyl)-3-(2-{3-[(1E)-N-hydroxyethanimidoyl]phenyl}propan-2-yl)urea | 8 |
| CPR | 6-CHLOROPURINE RIBOSIDE, 5'-MONOPHOSPHATE | 7 |
| MOA | MYCOPHENOLIC ACID | 7 |